Cargando…

Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease

Abnormal hyperphosphorylation of tau is pivotally involved in the pathogenesis of Alzheimer's disease (AD) and related tauopathies. Glycogen synthase kinase 3β (GSK-3β) is a primary tau kinase that is most implicated in tau pathology in AD. However, the exact molecular nature of GSK-3β involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Nana, Yin, Xiaomin, Yu, Dian, Cao, Maohong, Gong, Cheng-Xin, Iqbal, Khalid, Ding, Fei, Gu, Xiaosong, Liu, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313118/ https://www.ncbi.nlm.nih.gov/pubmed/25641096 http://dx.doi.org/10.1038/srep08187

Ejemplares similares

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
por: Dai, Chun-ling, et al.
Publicado: (2018)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018)

The Reduction of Tau Hyperphosphorylation by Cornel Iridoid Glycosides Is Mediated by Their Influence on Calpain Activity
por: Guo, Kaiwen, et al.
Publicado: (2022)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
por: Miao, Jin, et al.
Publicado: (2019)

Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice
por: Zhao, Yang, et al.
Publicado: (2014)

The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease
por: Hobday, Amy L, et al.
Publicado: (2021)

Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury
por: Hu, Wen, et al.
Publicado: (2018)

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
por: Basheer, Neha, et al.
Publicado: (2023)

Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice
por: Chen, Yanxing, et al.
Publicado: (2014)

The role of CDK5 and GSK3B kinases in hyperphosphorylation of microtubule associated protein tau (MAPT) in Alzheimer's disease
por: Jayapalan, Saranya, et al.
Publicado: (2013)

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease
por: Zhang, Bei, et al.
Publicado: (2016)

Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease
por: Borin, Mirta, et al.
Publicado: (2018)

Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer’s Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated
por: Barthélemy, Nicolas R., et al.
Publicado: (2022)

Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer’s Disease?
por: Dunning, Christopher J., et al.
Publicado: (2015)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss
por: Tiwari, Sachin Suresh, et al.
Publicado: (2016)

Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease
por: Ivanov, Stefan M., et al.
Publicado: (2020)

Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation
por: Antón-Fernández, Alejandro, et al.
Publicado: (2017)

Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation
por: Stefanoska, Kristie, et al.
Publicado: (2022)

Curcumin Downregulates GSK3 and Cdk5 in Scopolamine-Induced Alzheimer’s Disease Rats Abrogating Aβ(40/42) and Tau Hyperphosphorylation
por: Das, Tushar Kanti, et al.
Publicado: (2019)

Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau
por: Taylor, Henry B.C., et al.
Publicado: (2021)

Expression of Concern: Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
Publicado: (2023)

Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions
por: Liu, Mengyu, et al.
Publicado: (2020)

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
por: Zhu, Huazhang, et al.
Publicado: (2018)

GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats
por: Wei, Zhen, et al.
Publicado: (2019)

Differential Hyperphosphorylation of Tau-S199, -T231 and -S396 in Organotypic Brain Slices of Alzheimer Mice. A Model to Study Early Tau Hyperphosphorylation Using Okadaic Acid
por: Foidl, Bettina M., et al.
Publicado: (2018)

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
por: Ochalek, Anna, et al.
Publicado: (2017)

The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease
por: Liu, Zhenzhen, et al.
Publicado: (2015)

Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease☆
por: Zheng, Xianhong, et al.
Publicado: (2012)

Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease
por: Dong, Yue, et al.
Publicado: (2022)

Up-regulation of casein kinase 1ε is involved in tau pathogenesis in Alzheimer’s disease
por: Chen, Caoyi, et al.
Publicado: (2017)

Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression
por: Chen, Hsu-Hsin, et al.
Publicado: (2018)

Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer’s disease
por: Li, Shu-Qin, et al.
Publicado: (2015)

Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer's Disease
por: Yang, Wen, et al.
Publicado: (2020)

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau
por: Melov, Simon, et al.
Publicado: (2007)

Hyperphosphorylated tau in young and middle-aged subjects
por: Elobeid, Adila, et al.
Publicado: (2011)

PINCH in the Cellular Stress Response to Tau-Hyperphosphorylation
por: Ozdemir, Ahmet Yunus, et al.
Publicado: (2013)

Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
por: Tepper, Katharina, et al.
Publicado: (2014)

Immunological memory to hyperphosphorylated tau in asymptomatic individuals
por: Pascual, Gabriel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qqiumvgsleenj68bco1suad0ad